May 7, 2020 / 1:38 PM / 18 days ago

BRIEF-Xeris Pharmaceuticals Reports Q1 2020 Financial Results And Provides Corporate Updates

May 7 (Reuters) - Xeris Pharmaceuticals Inc:

* XERIS PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES

* Q1 LOSS PER SHARE $0.89

* Q1 EARNINGS PER SHARE ESTIMATE $-0.89 — REFINITIV IBES DATA

* XERIS PHARMACEUTICALS - AS OF MARCH 31, 2020, REPORTED TOTAL CASH, CASH EQUIVALENTS, INVESTMENTS OF $99.9 MILLION, COMPARED TO $88.8 MILLION AT DEC 31, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below